Need Help? Call 1­-866-­796-­7386
« back to stock screener

  CYTK stock: Cytokinetics, Inc.

Current Rating
Strong Sell

Previous Rating

Strong Sell
Our Stock Ratings
double the S&P500!
Learn more.
Company Statistics
Price
$9.60
Market Cap
458M
Sector
Health Care
Div. Growth
-
P/E
-
P/B
2.98
P/S
9.41
Dividend %
-
P/CF
4.6
P/FCF
85.0
Op. Cash Flow
100
FCF
0.1
Op. Margin
-148.50%
Net Margin
-172.30%
ROE
-62.60%
ROI
15.00%
ROA
-29.10%
EPS Growth
-
Current Ratio
4.8
Debt/Equity
29.00%
Company Price P/E Div. Yield Market Cap ($Mil) Rating
Tenet Healthcare Corp (THC) $17.24 - - 1.53B Strong Buy
NovaBay Pharmaceuticals, Inc. (NBY) $3.75 - - 55M Strong Buy
Birner Dental Mgmt Services In (BDMS) $7.25 - - 7.5M Strong Buy
Brainstorm Cell Therapeutics I (BCLI) $3.56 - - 57.1M Strong Buy
InfuSystem Holdings Inc (INFU) $2.35 - - 52.9M Strong Buy
Find great stocks now!
Avoid risky stocks
Enter your favorite tickers and click “Get Ratings”

Disclaimer

Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.

All analysis relies on publicly available financial information. Learn More